Home » Intellectual Property

Intellectual Property and Trade

Taking Stock: How Global Biotechnology Benefits from Intellectual Property Rights

This report examines the role played by IPRs in both upstream and downstream phases of the research, development and commercialization of biotechnology products and provides a review and analysis of the existing body of knowledge concerning the role of IPRs.

Bringing Innovation to Neglected Disease Research and Development: Joint Report by BIO and BIO Ventures for Global Health

BIO Ventures for Global Health (BVGH) and the Biotechnology Industry Organization (BIO) have collaborated on a new report that builds upon the findings in BVGH’s previous analysis, Developing New Drugs and Vaccines for Neglected Diseases of the Poor: The Product Developer Landscape.

IP: Imperative for Innovation

Patent systems can provide an advantage to society by rewarding the development of new inventions, promoting the advancement of technology and protecting the investor.  Patents often are the most important, and sometimes only, asset of a biotech company. Patents and related rights must be obtained in a timely and predictable manner and the ability to enforce those patents is critical.

BIO Bioprospecting Guidelines

Letters, Testimony & Comments

BIO Comments on Peruvian Biologics and Biosimilars Regulations
March 21 2013
BIO commends the Government of Peru for its endeavor to create a pathway for the approval of biological and biotechnological products....
BIO Comments on Colombia Biologics and Biosimilars Regulations
February 22 2013
BIO commends the government of Colombia for taking steps towards developing regulatory requirements for the registry of medicines of...
2013 Special 301 Submission: BIO Provides Input on Biotech IP Challenges Around the Globe
February 8 2013
Biotechnology companies provide unique benefits to the United States and the world. In the health care sector alone, the industry has...
BIO Comments on Brazil's ANVISA Public Consultation N°66/2012
February 1 2013
BIO respectfully submits both questions and comments for the National Health Surveillance Agency’s (ANVISA) consideration on the...
BIO Comments on India Guidelines for Examining Biotechnology Applications
January 18 2013
Given the importance of protections for basic biotechnology inventions to the survival of the biotechnology sector in India, BIO has...
More Letters, Testimony & Comments →

Press Releases

BIO Commends Supreme Court's Support for Continued Biotech Innovation
May 14 2013
Washington, D.C. (May 13, 2013) Jim Greenwood, president and CEO of the Biotechnology Industry Organization (BIO)...
BIO Urges U.S. Trade Representative to Preserve IP Protection Abroad
February 21 2011
WASHINGTON, D.C. (Monday, February 21, 2011) - The Biotechnology Industry Organization (BIO) stresses the critical...
BIO Commends USTR for Successfully Concluding U.S.-Korea Free Trade Agreement
April 17 2007
WASHINGTON, D.C. (April 16, 2007) -- The following statement was issued today by Biotechnology Industry Organization...